Line 4: |
Line 4: |
| ! Receptor !! Binding Affinity !! Effects !! Mechanism !! Agonists !! Antagonists | | ! Receptor !! Binding Affinity !! Effects !! Mechanism !! Agonists !! Antagonists |
| |- | | |- |
− | | α1 || Norepi > Epi >> Iso || Smooth muscle contraction || Gq, PLC -> IP3/DAG | + | | α1 || NE > Epi >> Iso |
| | | | | |
− | *Norepi | + | *Smooth muscle contraction, ↑SVR, ↑MAP |
− | *Phenylephrine | + | *Mydriasis, urethral sphincter contraction |
| + | | |
| + | G<sub>q</sub> → PLC → IP<sub>3</sub>/DAG → [Ca<sup>2+</sup>]<sub>i</sub> |
| + | | |
| + | *NE |
| + | *Phenylephrine (pure α1) |
| *Midodrine | | *Midodrine |
| | | | | |
− | *Phenoxybenzamine
| + | '''α1 selective:''' |
− | *Phentolamine
| |
| *Prazosin | | *Prazosin |
| *Tamsulosin | | *Tamsulosin |
− | *Trazodone
| |
| |- | | |- |
− | | α2 || Epi = Norepi >> Iso || Mixed effects || Gi, presynaptic, cAMP down | + | | α2 || Epi = NE >> Iso |
| + | | |
| + | *↑SVR, ↑MAP |
| + | *↓insulin release, ↓lipolysis, ↓aqueous humor production |
| + | | |
| + | presynaptic G<sub>i</sub> → ↓AC → ↓cAMP → ↓NT release |
| | | | | |
| *Dexmedetomidine | | *Dexmedetomidine |
| *Clonidine | | *Clonidine |
| | | | | |
| + | '''Non-selective:''' |
| *Phenoxybenzamine | | *Phenoxybenzamine |
| *Phentolamine | | *Phentolamine |
| *Trazodone | | *Trazodone |
| |- | | |- |
− | | β1 || Iso > Norepi > Epi || Chronotropy, Inotropy, Amylase secretion || Gs, cAMP up | + | | β1 || Iso > NE > Epi |
| + | | |
| + | *↑Chronotropy (myocytes), ↑Inotropy (SA node), ↑SBP |
| + | *↑Renin release/↑volume (JGA) |
| + | *Amylase secretion |
| + | | |
| + | G<sub>s</sub> → ↑AC → ↑cAMP |
| | | | | |
| *Dobutamine | | *Dobutamine |
Line 36: |
Line 51: |
| *Esmolol | | *Esmolol |
| |- | | |- |
− | | β2 || Iso > Epi > Norepi || Smooth muscle relaxation || Gs, cAMP up | + | | β2 || Iso > Epi > NE |
| + | | |
| + | *Smooth muscle relaxation, ↓SVR, ↓DBP, ↓MAP |
| + | *Bronchodilation |
| + | *↑Lipolysis, ↑Insulin release |
| + | *Relax uterine smooth muscle |
| + | *↑aqueous humor production |
| + | | |
| + | G<sub>s</sub> → ↑AC → ↑cAMP → ↑PKA |
| | | | | |
| *Albuterol | | *Albuterol |
Line 53: |
Line 76: |
| *Labet'''alol''' (anti-α1) | | *Labet'''alol''' (anti-α1) |
| |- | | |- |
− | | β3 || Iso > Epi = Norepi || Lipolysis, bladder detrusor relaxation || Gs, cAMP up | + | | β3 || Iso > Epi = NE |
| + | | |
| + | *Lipolysis |
| + | *Bladder detrusor relaxation |
| + | | |
| + | G<sub>s</sub> → ↑AC → ↑cAMP → ↑PKA |
| | | | | |
| *Mirabegron | | *Mirabegron |